CYBREXA Trademark

Trademark Overview

On Thursday, January 26, 2017, a trademark application was filed for CYBREXA with the United States Patent and Trademark Office. The USPTO has given the CYBREXA trademark a serial number of 87314496. The federal status of this trademark filing is REGISTERED as of Tuesday, September 22, 2020. This trademark is owned by Cybrexa, Inc.. The CYBREXA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services, namely, development of small molecule drugs for use in humans
cybrexa

General Information

Serial Number87314496
Word MarkCYBREXA
Filing DateThursday, January 26, 2017
Status700 - REGISTERED
Status DateTuesday, September 22, 2020
Registration Number6158410
Registration DateTuesday, September 22, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2017

Trademark Statements

Goods and ServicesPharmaceutical drug development services, namely, development of small molecule drugs for use in humans

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 30, 2017
Primary Code042
First Use Anywhere DateMonday, January 1, 2018
First Use In Commerce DateMonday, January 1, 2018

Trademark Owner History

Party NameCybrexa, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew Haven, CT 06511
Party NameCybrexa, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Haven, CT 06511
Party NameCybrexa, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Haven, CT 06511

Trademark Events

Event DateEvent Description
Tuesday, September 22, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, August 20, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, August 19, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 3, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 30, 2020USE AMENDMENT FILED
Thursday, July 30, 2020TEAS STATEMENT OF USE RECEIVED
Saturday, February 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 31, 2020EXTENSION 5 GRANTED
Tuesday, January 28, 2020EXTENSION 5 FILED
Friday, January 31, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 28, 2020TEAS EXTENSION RECEIVED
Thursday, July 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 16, 2019EXTENSION 4 GRANTED
Tuesday, July 16, 2019EXTENSION 4 FILED
Tuesday, July 16, 2019TEAS EXTENSION RECEIVED
Thursday, January 31, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 29, 2019EXTENSION 3 GRANTED
Tuesday, January 29, 2019EXTENSION 3 FILED
Tuesday, January 29, 2019TEAS EXTENSION RECEIVED
Tuesday, July 24, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 20, 2018EXTENSION 2 GRANTED
Friday, July 20, 2018EXTENSION 2 FILED
Friday, July 20, 2018TEAS EXTENSION RECEIVED
Tuesday, January 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 5, 2018EXTENSION 1 GRANTED
Friday, January 5, 2018EXTENSION 1 FILED
Friday, January 5, 2018TEAS EXTENSION RECEIVED
Tuesday, August 1, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 6, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 17, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 28, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 21, 2017ASSIGNED TO EXAMINER
Monday, January 30, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 30, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

cybrexa development molecule drugs small humans namely drug services pharmaceutical